Cargando…

Correction to: A rare overlap of statin-induced anti-3-hydroxy-3-methyl-glutaryl-coenzyme A necrotizing autoimmune myositis and dermatomyositis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464093/ https://www.ncbi.nlm.nih.gov/pubmed/36101659 http://dx.doi.org/10.1093/rap/rkac076

Ejemplares similares

A rare overlap of statin-induced anti-3-hydroxy-3-methyl-glutaryl-coenzyme A necrotizing autoimmune myositis and dermatomyositis
por: Parikh, Priya, et al.
Publicado: (2021)

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies
por: Drouot, Laurent, et al.
Publicado: (2014)

Statin-Induced Necrotizing Autoimmune Myositis
por: Akivis, Yonatan, et al.
Publicado: (2022)

Statin-Induced Necrotizing Autoimmune Myositis: Diagnosis and Management
por: Cha, David, et al.
Publicado: (2021)

Statin-Related Necrotizing Autoimmune Myositis: More Than Myalgia
por: Scheuing, William J, et al.
Publicado: (2022)

Statin-Induced Autoimmune Necrotizing Myositis: A Case Report
por: Almadhoun, Hussein, et al.
Publicado: (2022)

Correction: A Case of Suspected Statin-Related Delayed Onset Necrotizing Myositis
por: Smirlis, Elias, et al.
Publicado: (2022)

Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors
por: Roy, Satyajeet, et al.
Publicado: (2017)

Statin-naïve anti–3-hydroxy-3-methylglutaryl coenzyme A reductase antibody-positive necrotizing myopathy with heliotropic pseudoangioedema
por: Ortiz, Camila, et al.
Publicado: (2022)

Statin-Associated Necrotizing Autoimmune Myositis Complicated by an Uncommon Adverse Effect to Treatment
por: Fung, Brian M., et al.
Publicado: (2019)

In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase
por: Azmi, Muhammad Bilal, et al.
Publicado: (2021)

Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases
por: Chiang, Hui-Ling, et al.
Publicado: (2021)

The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease
por: Gomez, Sabas I, et al.
Publicado: (2014)

Redefining Dermatomyositis: A Description of New Diagnostic Criteria That Differentiate Pure Dermatomyositis From Overlap Myositis With Dermatomyositis Features
por: Troyanov, Yves, et al.
Publicado: (2014)

A Rapidly Debilitating Myopathy: A Rare Case of Statin-Induced Necrotizing Myositis
por: Ahmad, Anam, et al.
Publicado: (2021)

Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
por: Grünert, Sarah C., et al.
Publicado: (2022)

Near-Fatal Statin-Associated Autoimmune Myositis
por: Vithayathil, Mathew, et al.
Publicado: (2018)

Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies
por: Liang, Wen-Chen, et al.
Publicado: (2017)

Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy
por: Ghazal, Fatima, et al.
Publicado: (2023)

Nailfold capillaroscopy changes with disease activity in patients with inflammatory myositis including overlap myositis, pure dermatomyositis, and pure polymyositis
por: Shenavandeh, Saeedeh, et al.
Publicado: (2022)

In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against Naegleria fowleri
por: Hahn, Hye Jee, et al.
Publicado: (2020)

A Case of Suspected Statin-Related Delayed Onset Necrotizing Myositis
por: Smirlis, Elias, et al.
Publicado: (2022)

10. Warning: statin-induced autoimmune necrotising myositis
por: Jasim, Muhamad, et al.
Publicado: (2019)

Statin-Induced Triad of Autoimmune Myocarditis, Myositis, and Transaminitis
por: Ajmal, Muhammad, et al.
Publicado: (2021)

Statin-Induced Necrotizing Autoimmune Myopathy
por: Gawey, Brent, et al.
Publicado: (2020)

Statin-Induced Autoimmune Necrotizing Myopathy
por: Jayatilaka, Sahani, et al.
Publicado: (2021)

Dysphagia: A Case Report of an Atypical Presentation of Statin-Induced Necrotizing Myositis
por: Polmann, Michaela B, et al.
Publicado: (2023)

Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
por: Sharma, Priyadarshani, et al.
Publicado: (2019)

Statin‐induced autoimmune necrotizing myositis—A single‐center case series highlighting this potentially life‐threatening but treatable condition
por: Jasim, Muhamad, et al.
Publicado: (2020)

Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
por: Prevel, Nicolas, et al.
Publicado: (2014)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Dermatomyositis Sine Myositis with Membranoproliferative Glomerulonephritis
por: Owlia, Mohammad Bagher, et al.
Publicado: (2012)

Dermatomyositis sine myositis – Case presentation
por: Kaltsonoudis, Evripidis, et al.
Publicado: (2017)

Dermatomyositis with superimposed COVID-19 myositis
por: Balaini, Neeraj, et al.
Publicado: (2021)

Statins and Myotoxic Effects Associated With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies: An Observational Study in Japan
por: Watanabe, Yurika, et al.
Publicado: (2015)

Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype
por: Troyanov, Yves, et al.
Publicado: (2017)

COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?
por: Movahedi, Nasim, et al.
Publicado: (2021)

Clinical Significance of Myositis-Specific and Myositis-Associated Antibody Profiles in Dermatomyositis
por: Babu, Anuradha K., et al.
Publicado: (2022)

Refractory Statin-Induced Immune-Mediated Necrotizing Myositis: Challenges and Perils in Its Management
por: Yeo, Chong Hsien, et al.
Publicado: (2022)

Effect of Concomitant 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor Therapy on Creatine Phosphokinase Levels and Mortality Among Patients Receiving Daptomycin: Retrospective Cohort Study
por: McConnell, Heather L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3ldparier5qaor5dipi56kptcc